Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Organon & Co
OGN
$3.6B
| $2.04M | ﹤0.01% |
137,000
+32,957
| +32% | +$507K |
|
2577
Ingevity
NGVT
$2.62B
| $2.04M | ﹤0.01% |
51,503
-17,769
| -26% | -$786K |
|
2578
Agilon Health
AGL
$1.45B
| $2.04M | ﹤0.01% |
18,822
-5,292
| -22% | -$461K |
|
2579
Novartis
NVS
$288B
| $2.04M | ﹤0.01% |
18,273
+16,959
| +1,291% | +$1.81M |
|
2580
PUT
BioMarin Pharmaceuticals
BMRN
$13.6B
| $2.04M | ﹤0.01% |
28,800
+2,300
| +9% | +$155K |
|
2581
Granite Ridge Resources
GRNT
$665M
| $2.04M | ﹤0.01% |
334,773
+225,228
| +206% | +$1.39M |
|
2582
Stepan Co
SCL
$1.48B
| $2.03M | ﹤0.01% |
36,900
-9,788
| -21% | -$597K |
|
2583
Universal Corp
UVV
$1.13B
| $2.03M | ﹤0.01% |
36,210
-6,445
| -15% | -$344K |
|
2584
Vital Farms
VITL
$498M
| $2.02M | ﹤0.01% |
66,176
-28,127
| -30% | -$1.01M |
|
2585
CALL
Constellation Energy
CEG
$98.7B
| $2.02M | ﹤0.01% |
10,000
-376,000
| -97% | -$101M |
|
2586
Westamerica Bancorp
WABC
$1.38B
| $2.01M | ﹤0.01% |
39,787
-14,394
| -27% | -$733K |
|
2587
Marriott Vacations Worldwide
VAC
$4.1B
| $2.01M | ﹤0.01% |
31,335
+5,777
| +23% | +$459K |
|
2588
WisdomTree
WT
$3.44B
| $2.01M | ﹤0.01% |
225,540
-46,840
| -17% | -$436K |
|
2589
CALL
Amprius Technologies
AMPX
$1.74B
| $2.01M | ﹤0.01% |
750,000
-290,000
| -28% | -$856K |
|
2590
Helix Energy Solutions
HLX
$1.49B
| $2.01M | ﹤0.01% |
241,785
-109,448
| -31% | -$922K |
|
2591
Colliers International
CIGI
$5.15B
| $2M | ﹤0.01% |
16,525
+6,350
| +62% | +$832K |
|
2592
AtriCure
ATRC
$2.22B
| $2M | ﹤0.01% |
62,030
-24,511
| -28% | -$910K |
|
2593
Garrett Motion
GTX
$5.47B
| $2M | ﹤0.01% |
238,786
-170,174
| -42% | -$1.58M |
|
2594
PUT
Campbell Soup
CPB
$6.94B
| $2M | ﹤0.01% |
50,000
| – | – |
|
2595
XPEL
XPEL
$1.35B
| $1.99M | ﹤0.01% |
67,804
-12,544
| -16% | -$470K |
|
2596
Paysafe
PSFE
$405M
| $1.99M | ﹤0.01% |
126,908
+78,457
| +162% | +$1.42M |
|
2597
Newmark Group
NMRK
$2.68B
| $1.99M | ﹤0.01% |
163,500
-64,366
| -28% | -$859K |
|
2598
Dentsply Sirona
XRAY
$2.27B
| $1.99M | ﹤0.01% |
133,101
-216,011
| -62% | -$3.83M |
|
2599
Applied Optoelectronics
AAOI
$11B
| $1.98M | ﹤0.01% |
129,124
-88,676
| -41% | -$2.23M |
|
2600
Global X Uranium ETF
URA
$6.31B
| $1.98M | ﹤0.01% |
86,407
+26,130
| +43% | +$696K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.